Cited by 197Sodium Intake and HealthBlood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada

Open access
Joffres, Michel R., Campbell, Norm R.C., Manns, Braden, Tu, Karen·2007·Canadian Journal of Cardiology

Abstract

Background Hypertension is the leading risk factor for mortality worldwide. One-quarter of the adult Canadian population has hypertension, and more than 90% of the population is estimated to develop hypertension if they live an average lifespan. Reductions in dietary sodium additives significantly lower systolic and diastolic blood pressure, and population reductions in dietary sodium are recommended by major scientific and public health organizations.Objectives To estimate the reduction in hypertension prevalence and specific hypertension management cost savings associated with a population-wide reduction in dietary sodium additives.Methods Based on data from clinical trials, reducing dietary sodium additives by 1840 mg/day would result in a decrease of 5.06 mmHg (systolic) and 2.7 mmHg (diastolic) blood pressures. Using Canadian Heart Health Survey data, the resulting reduction in hypertension was estimated. Costs of laboratory testing and physician visits were based on 2001 to 2003 Ontario Health Insurance Plan data, and the number of physician visits and costs of medications for patients with hypertension were taken from 2003 IMS Canada. To estimate the reduction in total physician visits and laboratory costs, current estimates of aware hypertensive patients in Canada were used from the Canadian Community Health Survey.Results Reducing dietary sodium additives may decrease hypertension prevalence by 30%, resulting in one million fewer hypertensive patients in Canada, and almost double the treatment and control rate. Direct cost savings related to fewer physician visits, laboratory tests and lower medication use are estimated to be approximately $430 million per year. Physician visits and laboratory costs would decrease by 6.5%, and 23% fewer treated hypertensive patients would require medications for control of blood pressure.Conclusions Based on these estimates, lowering dietary sodium additives would lead to a large reduction in hypertension prevalence and result in health care cost savings in Canada.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0828-282x(07)70780-8

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • About 30% of hypertension is related to increased sodium (salt) consumption, and about 20% related to low dietary potassium (low fruit and vegetable intake).

    “About 30% of hypertension is related to increased sodium (salt) consumption, and about 20% related to low dietary potassium (low fruit and vegetable intake).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Advisory Board of the Second International Heart Health Conference. The Catalonia Declaration. Investing in heart health. 1995:1-85. <www.internationalhearthealth.org/Publications/ catalonia1995.pdf> (Version current at March 9, 2007).

Cited by

Sorted by citations

Authors
Joffres, M. R., Campbell, N. R. C., Manns, B., & Tu, K.
Affiliations
  • Simon Fraser University (CA)
  • Libin Cardiovascular Institute of Alberta (CA)
  • University of Calgary (CA)
  • University Health Network (CA)
Corresponding author
Campbell, Norm R.C.
Venue
Canadian Journal of Cardiology
Publisher
Elsevier BV
Published
2007-05
Volume
23
Issue
6
Pages
437-443
ISSN
0828-282X (ISSN-L)
OpenAlex
W1995049482
Cited by
197
References
49
Citations by year
2026: 2 · 2024: 5 · 2023: 1 · 2022: 8 · 2021: 12 · 2020: 9 · 2019: 9 · 2018: 8 · 2017: 14 · 2016: 8 · 2015: 10 · 2014: 13 · 2013: 15 · 2012: 20
FWCI
11.15
Type
journal article
Language
en
Open access
Locations
  • Canadian Journal of Cardiology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Heart and Stroke Foundation of Canada
  • Hypertension Canada
  • Health Canada
  • Canadian Institutes of Health Research
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
hypertension, blood pressure reduction, hypertension prevalence, healthcare cost reduction, physician visits, laboratory testing costs, antihypertensive medication use, Canada
MeSH terms
Canada, Cost-Benefit Analysis, Diet, Sodium-Restricted, Health Promotion, Health Surveys, Humans, Hypertension, Nutritional Requirements, Population Surveillance, Sodium, Dietary, Prevalence, Health Care Costs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review